A Bioequivalence Study of CT-L01 Compared to Co-administration (ALO 25 mg and MET XR 1,000 mg) in Healthy Volunteers

The requested reference [8675e119d7484c10cbca0cfa53c11368b44efb4b] no longer exists in our database. It has been replaced by the current reference: [4d5bdd0d4ab686086a0c2e042a2955d8ad746186]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a randomized, open, single-dose, crossover-design, phase 1, single-center study to evaluate bioequivalence after co-administration of ALO and MET XR or administration of CT-L01 in healthy volunteers.
Epistemonikos ID: 8b453ef14cebbfa9cd85aeb8b6776bd17ccc1ec2
First added on: May 13, 2024